Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
diarrhea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
The	O
patient	O
is	O
a	O
___	O
yo	O
woman	O
with	O
PMH	O
notable	O
for	O
CHF	O
(EF30%),	O
Afib	O
and	O
dementia	B-Dementia
who	O
presents	O
with	O
diarrhea.	O
Pt	O
unable	O
to	O
provide	O
reliable	O
history	O
(because	O
of	O
dementia)	B-Dementia
and	O
thus	O
history	O
was	O
obtained	O
from	O
the	O
pt's	O
son	O
and	O
assisted	O
living	O
facility.	O
The	O
son	O
reports	O
that	O
pt	O
was	O
recently	O
admitted	O
to	O
a	O
___	O
hospital	O
for	O
falls	B-Falls
and	O
discharged	O
on	O
ciprofloxacin	O
(unclear	O
indication)	O
to	O
a	O
rehab	O
facility.	O
While	O
in	O
the	O
rehab	O
facility,	O
she	O
developed	O
C.diff	O
colitis	O
and	O
was	O
treated	O
with	O
an	O
antibiotic	O
(possibly	O
Flagyl).	O
Per	O
the	O
son,	O
he	O
thought	O
the	O
diarrhea	O
resolved	O
by	O
the	O
time	O
she	O
was	O
moved	O
on	O
___	O
to	O
an	O
assisted	O
living	O
facility	O
in	O
___	O
(to	O
be	O
closer	O
to	O
the	O
son).	O
Per	O
the	O
facility,	O
the	O
diarrhea	O
never	O
resolved	O
and	O
she	O
was	O
changed	O
to	O
PO	O
Vancomycin	O
beginning	O
___.	O
This	O
course	O
was	O
finished	O
on	O
___	O
and	O
with	O
what	O
they	O
thought	O
was	O
resolution	O
of	O
the	O
diarrhea	O
on	O
___.	O
Unfortunately,	O
it	O
recurred	O
within	O
a	O
day	O
and	O
she	O
was	O
brought	O
to	O
the	O
ED	O
for	O
assessment.	O
In	O
the	O
ED,	O
initial	O
VS:	O
97.9	O
81	O
126/97	O
18	O
100%	O
RA.	O
Exam	O
notable	O
for	O
guaiac	O
positive	O
stool	O
and	O
possible	O
complaints	O
of	O
shortness	O
of	O
breath.	O
EKG	O
showed	O
AF,	O
LAD,	O
RBBB,	O
no	O
ischemic	O
changes.	O
CXR	O
showed	O
findings	O
suggestive	O
of	O
congestive	O
failure	O
with	O
small	O
left	O
pleural	O
effusion	O
and	O
mild	O
pulmonary	O
edema.	O
Non-contrast	O
head	O
CT	O
showed	O
no	O
acute	O
process.	O
Labs	O
notable	O
for	O
BNP	O
32685,	O
TroT	O
0.06,	O
Na	O
131,	O
WBC	O
10.8	O
with	O
85%N,	O
Hct	O
35	O
(baseline).	O
She	O
was	O
given	O
500mL	O
NS,	O
ASA	O
325mg.	O
Vitals	O
prior	O
to	O
transfer:	O
98.1	O
124/71	O
79	O
20	O
96%	O
RA.	O
Currently,	O
she	O
is	O
without	O
complaints	O
except	O
sleepiness.	O
Denies	O
SOB,	O
fever,	O
abdominal	O
pain,	O
CP.	O
Past	O
Medical	O
History:	O
-HTN	O
-atrial	O
fibrillation	O
-breast	O
cancer	O
s/p	O
lumpectomy	O
-dementia	I-Delirium
-Hyponatremia	O
-Cataracts	I-Visual_impairment
-CHF	O
(EF	O
30%)	O
Social	O
History:	O
___	O
Family	O
History:	O
noncontributory	O
Physical	O
Exam:	O
Admission	O
PE:	O
VS	O
-	O
96.8F,	O
BP	O
109/79,	O
HR	O
60,	O
R	O
18,	O
O2-sat	O
100%	O
RA	O
___	O
-	O
oriented	B-Unspecified_cognitive_impairment
to	O
hospital,	O
not	O
year;	O
can	O
say	O
the	O
days	O
of	O
the	O
week	O
forward	O
and	O
backwards	O
with	O
some	O
coaching	O
and	O
hesitation	O
GENERAL	O
-	O
elderly	O
female	O
in	O
NAD,	O
comfortable	O
LUNGS	O
-	O
mild	O
bibasilar	O
crackles	O
L>R	O
HEART	O
-	O
irregularly	O
irregular,	O
no	O
MRG	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND	O
EXTREMITIES	O
-	O
WWP,	O
2+	O
pitting	O
edema	O
to	O
mid	O
calf	O
b/l	O
Discharge	O
PE:	O
VS	O
-	O
97.4F,	O
BP	O
140/86,	O
HR	O
90,	O
R	O
18,	O
O2-sat	O
98%	O
RA	O
GENERAL	O
-	O
elderly	O
female	O
in	O
NAD	O
LUNGS	O
-	O
clear	O
to	O
auscultation	O
bilaterally	O
HEART	O
-	O
irregularly	O
irregular,	O
no	O
MRG	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND	O
EXTREMITIES	O
-	O
WWP,	O
1+	O
pitting	O
edema	O
to	O
mid	O
calf	O
b/l	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
___	O
04:30PM	O
BLOOD	O
WBC-10.8#	O
RBC-3.90*	O
Hgb-11.9*	O
Hct-35.1*	O
MCV-90	O
MCH-30.6	O
MCHC-34.0	O
RDW-13.2	O
Plt	O
___	O
___	O
04:30PM	O
BLOOD	O
Neuts-85.0*	O
Lymphs-10.9*	O
Monos-3.0	O
Eos-0.9	O
Baso-0.3	O
___	O
04:30PM	O
BLOOD	O
Glucose-75	O
UreaN-14	O
Creat-0.9	O
Na-131*	O
K-4.2	O
Cl-96	O
HCO3-25	O
AnGap-14	O
___	O
04:30PM	O
BLOOD	O
ALT-10	O
AST-15	O
AlkPhos-73	O
TotBili-1.0	O
___	O
04:30PM	O
BLOOD	O
cTropnT-0.06*	O
___	O
___	O
04:30PM	O
BLOOD	O
Albumin-3.3*	O
Calcium-9.6	O
Phos-2.5*	O
Mg-1.7	O
___	O
07:00PM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-NEG	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-5.5	O
Leuks-NEG	O
Discharge	O
Labs:	O
___	O
06:15AM	O
BLOOD	O
WBC-5.1	O
RBC-3.67*	O
Hgb-11.1*	O
Hct-32.7*	O
MCV-89	O
MCH-30.3	O
MCHC-34.0	O
RDW-13.2	O
Plt	O
___	O
___	O
06:15AM	O
BLOOD	O
Glucose-57*	O
UreaN-15	O
Creat-1.4*	O
Na-129*	O
K-4.6	O
Cl-92*	O
HCO3-24	O
AnGap-18	O
___	O
06:15AM	O
BLOOD	O
Calcium-9.3	O
Phos-3.1	O
Mg-1.8	O
Microbiology:	O
--___	O
STOOL	O
MICROSPORIDIA	O
STAIN	O
(Preliminary):	O
PENDING	O
CYCLOSPORA	O
STAIN	O
(Final	O
___:	O
NO	O
CYCLOSPORA	O
SEEN.	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Positive	O
for	O
toxigenic	O
C.	O
difficile	O
by	O
the	O
Illumigene	O
DNA	O
amplification.	O
(Reference	O
Range-Negative).	O
FECAL	O
CULTURE	O
(Final	O
___:	O
NO	O
SALMONELLA	O
OR	O
SHIGELLA	O
FOUND.	O
CAMPYLOBACTER	O
CULTURE	O
(Final	O
___:	O
NO	O
CAMPYLOBACTER	O
FOUND.	O
FECAL	O
CULTURE	O
-	O
R/O	O
VIBRIO	O
(Final	O
___:	O
NO	O
VIBRIO	O
FOUND.	O
FECAL	O
CULTURE	O
-	O
R/O	O
YERSINIA	O
(Final	O
___:	O
NO	O
YERSINIA	O
FOUND.	O
FECAL	O
CULTURE	O
-	O
R/O	O
E.COLI	O
0157:H7	O
(Final	O
___:	O
NO	O
E.COLI	O
0157:H7	O
FOUND.	O
Cryptosporidium/Giardia	O
(DFA)	O
(Final	O
___:	O
NO	O
CRYPTOSPORIDIUM	O
OR	O
GIARDIA	O
SEEN.	O
--URINE	O
CULTURE	O
(Final	O
___:	O
KLEBSIELLA	O
PNEUMONIAE.	O
>100,000	O
ORGANISMS/ML..	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
Piperacillin/tazobactam	O
sensitivity	O
testing	O
available	O
on	O
request.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
KLEBSIELLA	O
PNEUMONIAE	O
|	O
AMPICILLIN/SULBACTAM--	O
4	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
EKG	O
___:	O
Atrial	O
fibrillation	O
with	O
a	O
controlled	O
ventricular	O
response	O
rate	O
of	O
77	O
beats	O
per	O
minute.	O
Right	O
bundle-branch	O
block	O
with	O
left	O
anterior	O
fascicular	O
block.	O
Probable	O
prior	O
inferior	O
myocardial	O
infarction.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
the	O
ventricular	O
response	O
rate	O
is	O
faster.	O
Radiology:	O
___	O
CT	B-Intracranial_haemorrhage
Head	B-Intracranial_haemorrhage
w/o	O
contrast:	O
IMPRESSION:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	O
___	O
CXR	O
(PA	O
and	O
Lateral):IMPRESSION:	O
Findings	O
suggestive	O
of	O
congestive	O
failure	O
with	O
small	O
left	O
pleural	O
effusion	O
and	O
mild	O
pulmonary	O
edema.	O
Hyperinflation.	O
___	O
CXR	O
(Portable	O
AP):	O
IMPRESSION:	O
Slight	O
interval	O
increase	O
in	O
mild	O
to	O
moderate	O
pulmonary	O
edema,	O
with	O
a	O
small	O
to	O
moderate	O
left	O
pleural	O
effusion.	O
The	O
cardiac	O
silhouette	O
remains	O
enlarged.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
chronic	O
systolic	O
CHF,	O
recurrent	O
C.	O
diff	O
infection,	O
AFib	O
who	O
presents	O
with	O
continued	O
diarrhea,	O
dyspnea,	O
and	O
pedal	O
edema.	O
Acute	O
issues:	O
#	O
C.	O
diff.	O
colitis	O
-	O
The	O
patient	O
was	O
treated	O
with	O
a	O
full	O
course	O
of	O
Flagyl	O
PO	O
without	O
resolution	O
of	O
diarrhea/C.	O
diff	O
colitis	O
and	O
just	O
finished	O
a	O
3	O
week	O
course	O
of	O
Vancomycin	O
250mg	O
PO	O
q6hrs	O
when	O
diarrhea	O
recurred,	O
for	O
which	O
pt	O
was	O
admitted.	O
C.	O
diff	O
was	O
positive	O
again	O
on	O
this	O
admission.	O
GI	O
was	O
consulted	O
who	O
recommended	O
prolonged	O
taper	O
of	O
Vancomycin	O
PO	O
which	O
was	O
started	O
at	O
500mg	O
PO	O
q6hrs.	O
Pt	O
had	O
___	O
BM	O
/	O
day	O
at	O
start	O
of	O
admission	O
which	O
decreased	O
by	O
discharge.	O
#	O
Acute	O
on	O
chronic	O
congestive	O
heart	O
failure	O
-	O
Pt	O
intermittently	O
complained	O
of	O
shortness	O
of	O
breath	O
during	O
admission.	O
Her	O
home	O
PO	O
lasix	O
was	O
held	O
and	O
she	O
was	O
given	O
IV	O
Lasix	O
for	O
diuresis.	O
Pt	O
was	O
discharged	O
on	O
a	O
higher	O
dose	O
of	O
PO	O
lasix	O
(40mg	O
PO)	O
as	O
current	O
home	O
regimen	O
(20mg)	O
was	O
insufficient	O
to	O
maintain	O
her	O
euvolemic.	O
She	O
maintained	O
an	O
O2	O
sat	O
>95%	O
throughout	O
the	O
admission.	O
Her	O
home	O
spironolactone	O
and	O
ASA	O
were	O
continued.	O
Pt	O
was	O
started	O
on	O
Lisinopril	O
2.5mg	O
PO	O
daily.	O
#	O
UTI	B-Urinary_tract_infection
-	O
Pt	O
had	O
asymptomatic	O
bacturia	O
which	O
was	O
treated	O
due	O
to	O
concern	O
for	O
a	O
morning	O
of	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Pt	O
received	O
Bactrim	O
DS	O
1	O
tab	O
BID	O
x	O
3	O
days.	O
Her	O
course	O
was	O
completed	O
prior	O
to	O
discharge.	O
#	O
Hyponatremia:	O
Had	O
been	O
hyponatremic	O
on	O
previous	O
admission.	O
Initially	O
thought	O
to	O
be	O
hypervolemic	O
hyponatremia	O
from	O
CHF.	O
Pt	O
was	O
kept	O
on	O
1500mL	O
fluid	O
restriction.	O
However,	O
while	O
Na	O
initially	O
started	O
to	O
improve	O
with	O
diuresis	O
it	O
failed	O
to	O
return	O
to	O
normal.	O
Pt	O
was	O
discharged	O
with	O
Na	O
129.	O
This	O
was	O
thought	O
to	O
be	O
over-diuresis	O
vs.	O
heart	O
failure.	O
Chronic	O
issues:	O
#	O
Atrial	O
fibrillation:	O
CHADS2	O
of	O
3,	O
but	O
not	O
on	O
Coumadin	O
due	O
to	O
fall	B-Falls
risk.	B-Falls
Rate	O
controlled.	O
Pt	O
experienced	O
bradycardia	O
on	O
b-blocker	O
during	O
previous	O
admission	O
and	O
so	O
it	O
was	O
not	O
added	O
to	O
her	O
regimen.	O
We	O
continued	O
ASA	O
325mg	O
PO	O
daily.	O
Pt	O
is	O
not	O
on	O
Coumadin	O
due	O
to	O
fall	B-Falls
risk.	B-Falls
#	O
Anemia:	O
Per	O
previous	O
admission,	O
iron	O
studies	O
were	O
consistent	O
with	O
anemia	O
of	O
chronic	O
disease.	O
Pt	O
was	O
found	O
to	O
be	O
guaiac	O
positive	O
in	O
ED	O
at	O
this	O
admission.	O
Hct	O
was	O
trended	O
(stable)	O
and	O
pt	O
was	O
stable.	O
#	O
Dementia:	B-Dementia
Stable	O
througout	O
admission.	O
Oriented	B-Unspecified_cognitive_impairment
to	O
person,	O
"hospital",	O
not	O
oriented	B-Unspecified_cognitive_impairment
to	O
year.	O
Able	O
to	O
recite	O
days	O
of	O
week	O
forward	O
and	O
backward	O
with	O
significant	O
prompting	O
and	O
hesitation.	O
Continued	O
home	O
Donepezil	O
and	O
mirtazapine.	O
Transitional	O
issues:	O
#	O
Electrolytes:	O
Lasix	O
dose	O
increased	O
and	O
ACEI	O
added	O
this	O
admission.	O
Should	O
get	O
electrolytes	O
checked	O
___	O
and	O
continued	O
every	O
other	O
day.	O
#	O
Risk	O
for	O
readmission:	O
Pt	O
with	O
significant	O
dementia	B-Dementia
requiring	O
24hr	O
care.	O
Medications	O
on	O
Admission:	O
Preadmission	O
medications	O
listed	O
are	O
correct	O
and	O
complete.	O
Information	O
was	O
obtained	O
from	O
Pharmacy.	O
1.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
3.	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO	O
QID	O
4.	O
Spironolactone	O
25	O
mg	O
PO	O
DAILY	O
Hold	O
for	O
SBP<100	O
5.	O
saccharomyces	O
boulardii	O
*NF*	O
250	O
mg	O
Oral	O
BID	O
6.	O
Oyst-Cal-D	O
500	O
*NF*	O
(calcium	O
carbonate-vitamin	O
D3)	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Oral	O
daily	O
7.	O
Mirtazapine	O
7.5	O
mg	O
PO	O
HS	O
8.	O
Donepezil	O
5	O
mg	O
PO	O
HS	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Donepezil	O
5	O
mg	O
PO	O
HS	O
3.	O
Mirtazapine	O
7.5	O
mg	O
PO	O
HS	O
4.	O
Spironolactone	O
25	O
mg	O
PO	O
DAILY	O
Hold	O
for	O
SBP<100	O
5.	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO	O
Q6H	O
6.	O
Oyst-Cal-D	O
500	O
*NF*	O
(calcium	O
carbonate-vitamin	O
D3)	O
500	O
mg(1,250mg)	O
-200	O
unit	O
Oral	O
daily	O
7.	O
Vancomycin	O
Taper	O
Regimen	O
Please	O
continue	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO	O
q6hrs	O
x	O
7	O
days.	O
Then,	O
decrease	O
to	O
250mg	O
PO	O
q6hrs	O
x	O
7	O
days	O
Then,	O
decrease	O
to	O
125mg	O
PO	O
q6hrs	O
x	O
7	O
days	O
Then,	O
decrease	O
to	O
125mg	O
PO	O
q12hrs	O
x	O
7	O
days	O
Then,	O
decrease	O
to	O
125mg	O
PO	O
q24hrs	O
x	O
7	O
days	O
Then,	O
decrease	O
to	O
125mg	O
PO	O
every	O
other	O
day	O
x	O
7	O
days	O
Then,	O
decrease	O
to	O
125mg	O
PO	O
every	O
3	O
days	O
x	O
14	O
days	O
8.	O
Probiotic	O
Please	O
start	O
Saccharomyces	O
boulardii	O
500	O
mg	O
orally	O
twice	O
daily	O
to	O
be	O
overlapped	O
with	O
the	O
final	O
week	O
of	O
the	O
taper	O
and	O
continued	O
for	O
two	O
additional	O
weeks	O
in	O
the	O
absence	O
of	O
antibiotics.	O
9.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
10.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
Hold	O
for	O
SBP<100	O
or	O
HR<60	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
C.	O
difile	O
colitis	O
Dementia	B-Dementia
Congestive	O
heart	O
failure	O
Atrial	O
fibrillation	O
Hyponatremia	O
Discharge	O
Condition:	O
Stable.	O
Oriented	B-Unspecified_cognitive_impairment
to	O
person	O
and	O
'hospital',	O
not	O
year.	O
Able	O
to	O
say	O
days	O
of	O
the	O
weeks	O
forward	O
and	O
backward	O
with	O
significant	O
prompting.	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
with	O
diarrhea	O
and	O
found	O
to	O
have	O
recurrent	O
C.	O
diffile	O
colitis.	O
Gastroenterology	O
was	O
consulted	O
who	O
recommended	O
a	O
long	O
taper	O
of	O
an	O
antibiotic	O
called	O
Vancomycin.	O
We	O
also	O
had	O
physical	O
therapy	O
see	O
you	O
and	O
they	O
recommended	O
either	O
rehab	O
or	O
24	O
hour	O
care	O
to	O
help	O
with	O
your	O
activities	O
of	O
daily	O
living	O
and	O
medical	O
care.	O
We	O
also	O
noted	O
you	O
had	O
some	O
bacteria	O
in	O
your	O
urine.	O
We	O
treated	O
you	O
with	O
antibiotics	O
and	O
you	O
completed	O
a	O
full	O
course.	O
Please	O
weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
It	O
is	O
very	O
important	O
that	O
you	O
get	O
your	O
electrolytes	O
checked	O
on	O
___.	O
We	O
increased	O
your	O
daily	O
dose	O
of	O
lasix	O
and	O
this	O
can	O
affect	O
the	O
salt	O
balance	O
in	O
your	O
blood.	O
INCREASE	O
Lasix	O
PO	O
to	O
40mg	O
daily	O
START	O
Vancomycin	O
Oral	O
Liquid	O
___	O
PO	O
q6hrs	O
and	O
follow	O
long	O
taper	O
as	O
listed.	O
We	O
expect	O
that	O
you	O
will	O
stay	O
in	O
the	O
extended	O
care	O
facility	O
for	O
<30	O
days.	O
Followup	O
Instructions:	O
___	O

